Authors: Motzer, RJ Rakhit, A Ginsberg, M Rittweger, K Vuky, J Yu, R Fettner, S Hooftman, L

Citation: Rj. Motzer et al., Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma, J CL ONCOL, 19(5), 2001, pp. 1312-1319

Authors: Rakhit, A Yeon, MM Ferrante, J Fettner, S Nadeau, R Motzer, R Bukowski, R Carvajal, DM Wilkinson, VL Presky, DH Magram, J Gately, MK

Citation: A. Rakhit et al., Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice, CLIN PHARM, 65(6), 1999, pp. 615-629